These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immune modulating nanoparticles for the treatment of ocular diseases. Fang L; Liu J; Liu Z; Zhou H J Nanobiotechnology; 2022 Nov; 20(1):496. PubMed ID: 36424630 [TBL] [Abstract][Full Text] [Related]
3. The Therapeutic Benefits of Nanoencapsulation in Drug Delivery to the Anterior Segment of the Eye: A Systematic Review. Bhandari M; Nguyen S; Yazdani M; Utheim TP; Hagesaether E Front Pharmacol; 2022; 13():903519. PubMed ID: 35645827 [No Abstract] [Full Text] [Related]
4. Recent Advances in the Design of Topical Ophthalmic Delivery Systems in the Treatment of Ocular Surface Inflammation and Their Biopharmaceutical Evaluation. Mazet R; Yaméogo JBG; Wouessidjewe D; Choisnard L; Gèze A Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32575411 [TBL] [Abstract][Full Text] [Related]
5. Dexibuprofen Biodegradable Nanoparticles: One Step Closer towards a Better Ocular Interaction Study. Sánchez-López E; Esteruelas G; Ortiz A; Espina M; Prat J; Muñoz M; Cano A; Calpena AC; Ettcheto M; Camins A; Alsafi Z; Souto EB; García ML; Pujol M Nanomaterials (Basel); 2020 Apr; 10(4):. PubMed ID: 32290252 [TBL] [Abstract][Full Text] [Related]
6. Emerging role of nanosuspensions in drug delivery systems. Jacob S; Nair AB; Shah J Biomater Res; 2020; 24():3. PubMed ID: 31969986 [TBL] [Abstract][Full Text] [Related]
7. Preparation and Evaluation of Eudragit® L100 Nanoparticles Loaded Impregnated with KT Tromethamine Loaded PVA -HEC Insertions for Ophthalmic Drug Delivery. Mohammadi G; Mirzaeei S; Taghe S; Mohammadi P Adv Pharm Bull; 2019 Oct; 9(4):593-600. PubMed ID: 31857963 [No Abstract] [Full Text] [Related]
8. Novel ultra-small micelles based on ginsenoside Rb1: a potential nanoplatform for ocular drug delivery. Li M; Lan J; Li X; Xin M; Wang H; Zhang F; Lu X; Zhuang Z; Wu X Drug Deliv; 2019 Dec; 26(1):481-489. PubMed ID: 30957571 [TBL] [Abstract][Full Text] [Related]
9. Ultra-small micelles based on polyoxyl 15 hydroxystearate for ocular delivery of myricetin: optimization, in vitro, and in vivo evaluation. Hou Y; Zhang F; Lan J; Sun F; Li J; Li M; Song K; Wu X Drug Deliv; 2019 Dec; 26(1):158-167. PubMed ID: 30822157 [TBL] [Abstract][Full Text] [Related]
10. Parenteral nanosuspensions: a brief review from solubility enhancement to more novel and specific applications. Ahire E; Thakkar S; Darshanwad M; Misra M Acta Pharm Sin B; 2018 Sep; 8(5):733-755. PubMed ID: 30245962 [TBL] [Abstract][Full Text] [Related]
11. Nanoparticles for drug delivery to the anterior segment of the eye. Janagam DR; Wu L; Lowe TL Adv Drug Deliv Rev; 2017 Dec; 122():31-64. PubMed ID: 28392306 [TBL] [Abstract][Full Text] [Related]
12. Conjugation of cell-penetrating peptides with poly(lactic-co-glycolic acid)-polyethylene glycol nanoparticles improves ocular drug delivery. Vasconcelos A; Vega E; Pérez Y; Gómara MJ; García ML; Haro I Int J Nanomedicine; 2015; 10():609-31. PubMed ID: 25670897 [TBL] [Abstract][Full Text] [Related]
13. Clavanin bacterial sepsis control using a novel methacrylate nanocarrier. Saúde AC; Ombredane AS; Silva ON; Barbosa JA; Moreno SE; Araujo AC; Falcão R; Silva LP; Dias SC; Franco OL Int J Nanomedicine; 2014; 9():5055-69. PubMed ID: 25382976 [TBL] [Abstract][Full Text] [Related]
14. Ocular drug delivery: a clue from nanotechnology. Bucolo C; Drago F; Salomone S Front Pharmacol; 2012; 3():188. PubMed ID: 23125835 [No Abstract] [Full Text] [Related]
15. Targeted drug-delivery approaches by nanoparticulate carriers in the therapy of inflammatory diseases. Ulbrich W; Lamprecht A J R Soc Interface; 2010 Feb; 7 Suppl 1(Suppl 1):S55-66. PubMed ID: 19940000 [TBL] [Abstract][Full Text] [Related]